Diabetes
Conditions
Interventions
Gold Standard:glucose/lactic acid analyzer produced by American YSI company
blood 
system 
by 
Medtrum 
Technologies 
Inc.
Sponsors
Shanghai Sixth People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Diabetics patients aged 18-75 years; 2. Patients with type 1 or type 2 diabetes who have been diagnosed for more than 3 months and are currently using insulin; 3. who have not participated in other clinical verifiers (if they have recently participated in a drug clinical study, it must be more than one month after the termination of the clinical study;If participants have participated in an instrument clinical study, they must be more than 2 weeks after the termination of the clinical study. Diabetics in the observation trial enrollment phase (no experimental or instrumental operation is required) are allowed to participate; 4. Volunteer and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with acute complications such as diabetic ketoacidosis and nonketotic hyperosmolar syndrome; 2. Severe chronic complications of diabetes, heart, liver and kidney diseases and other systemic diseases; 3. Patients with severe circulatory disorders; 4. Patients with pregnancy, psychosis, immunosuppression disorder, systemic neuropathy; 5. Coexisting with other diseases and having a life expectancy of less than one year; 6. Severe allergy history, allergy to hypodermic infusion tube or adhesive; 7. Anemia patients; 8. Patients considered unfit to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma glucose concentration in venous blood; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood sugar levels in the fingertips; | — |
Countries
China
Contacts
Public ContactYuqian Bao
Shanghai Sixth People's Hospital
Outcome results
None listed